\-\ Texto\\:\\ \ \(0\)\
\-\ tender\\ mass\\ right\\ parietal\\ bone\\.\ \(0\)\
\-\ multimodality\\ approach\\ with\\ chemotherapy\\ and\\ radiation\\ therapy\\.\ \(0\)\
\-\ mr\\ \\-\\ enhancing\\ mass\\ right\\ parietal\\ bone\\.\ \(0\)\
\-\ nm\\ bone\\ scan\\ \\-\\ increase\\ uptake\\ right\\ parietal\\ bone\ \(0\)\
\-\ metastatic\\ neuroblastoma\ \(2\)\
\-\ \\â\\€\\¢\\ osteomyelitis\ \(1\)\
\-\ \\â\\€\\¢\\ trauma\ \(16\)\
\-\ \\â\\€\\¢\\ langerhans\\ histiocytosis\ \(0\)\
\-\ \\â\\€\\¢\\ metastasis\ \(6\)\
\-\ 9\\ year\\ old\\ boy\\ with\\ 2\\ year\\ history\\ of\\ \\?\\?\\?\\?\\?\\?\\?\\?\\?\\?\\.\ \(1\)\
\-\ developed\\ a\\ new\\ painful\\ mass\\ of\\ the\\ right\\ parietal\\ bone\\.\ \(0\)\
\-\ this\\ 9\\ year\\ old\\ boy\\ had\\ 2\\ year\\ history\\ of\\ neuroblastoma\\,\\ when\\ he\\ developed\\ a\\ painful\\ mass\\ of\\ the\\ right\\ parietal\\ bone\\,\\ metastasis\\ was\\ the\\ primary\\ concern\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\?\\:\\ 0\\.3237747087984958\ \(0\)\
\-\ parietal\\:\\ 0\\.17722002184674682\ \(0\)\
\-\ bone\\:\\ 0\\.12369522416271088\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.08295579886789309\ \(0\)\
\-\ painful\\:\\ 0\\.07887239287107055\ \(0\)\
\-\ multimodality\\:\\ 0\\.07492141878930474\ \(0\)\
\-\ 9\\:\\ 0\\.06858863485880601\ \(0\)\
\-\ developed\\:\\ 0\\.06388476669581969\ \(0\)\
\-\ nm\\:\\ 0\\.06323236243662575\ \(0\)\
\-\ metastasis\\:\\ 0\\.06211159856893061\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.060854926275568454\ \(0\)\
\-\ boy\\:\\ 0\\.05640236465875672\ \(0\)\
\-\ langerhans\\:\\ 0\\.04907105153663044\ \(0\)\
\-\ histiocytosis\\:\\ 0\\.0461657807128163\ \(0\)\
\-\ mass\\:\\ 0\\.046153825512526774\ \(0\)\
\-\ right\\:\\ 0\\.04376852956846683\ \(0\)\
\-\ approach\\:\\ 0\\.04354160275417638\ \(0\)\
\-\ concern\\:\\ 0\\.04127349740289963\ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.03855661492726123\ \(0\)\
\-\ year\\:\\ 0\\.03713030171933649\ \(0\)\
\-\ 2\\:\\ 0\\.03573018439826303\ \(0\)\
\-\ \\-\\:\\ 0\\.035567542887541034\ \(0\)\
\-\ increase\\:\\ 0\\.03480009521467875\ \(0\)\
\-\ tender\\:\\ 0\\.0336738921674663\ \(0\)\
\-\ uptake\\:\\ 0\\.03296100412324478\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.029737337719814225\ \(0\)\
\-\ new\\:\\ 0\\.028910562881558816\ \(0\)\
\-\ radiation\\:\\ 0\\.02722574028701297\ \(0\)\
\-\ mr\\:\\ 0\\.026361159921810037\ \(0\)\
\-\ enhancing\\:\\ 0\\.026018966338686982\ \(0\)\
\-\ primary\\:\\ 0\\.02457654624170579\ \(0\)\
\-\ when\\:\\ 0\\.023760497452582578\ \(0\)\
\-\ scan\\:\\ 0\\.02322593650905804\ \(0\)\
\-\ he\\:\\ 0\\.02314744992265067\ \(0\)\
\-\ history\\:\\ 0\\.022916787139943363\ \(0\)\
\-\ trauma\\:\\ 0\\.022689405648135232\ \(0\)\
\-\ therapy\\:\\ 0\\.022180978604277795\ \(0\)\
\-\ metastatic\\:\\ 0\\.02088455731666107\ \(0\)\
\-\ had\\:\\ 0\\.017901454555735028\ \(0\)\
\-\ old\\:\\ 0\\.016989021298296204\ \(0\)\
\-\ was\\:\\ 0\\.009594927400132881\ \(0\)\
\-\ this\\:\\ 0\\.009331429255477018\ \(0\)\
\-\ a\\:\\ 0\\.007700967025603907\ \(0\)\
\-\ \\,\\:\\ 0\\.005256506126549269\ \(0\)\
\-\ of\\:\\ 0\\.004524419448465569\ \(0\)\
\-\ the\\:\\ 0\\.004026678195251237\ \(0\)\
\-\ with\\:\\ 0\\.002271925749318247\ \(0\)\
\-\ \\.\\:\\ 0\\.002067934141592987\ \(0\)\
\-\ and\\:\\ 0\\.0017476602498273635\ \(0\)\
